海外の治験の状況「%E8%84%B3%E5%8D%92%E4%B8%AD」での検索結果
55件の検索結果
- 進捗状況
- 試験名
- 対象疾患名
- 国名
- 登録日
Authorised
- 221AD301 Phase 3 Study of Aducanumab in Early Alzheimer's Disease
- Early Alzheimer's Disease MedDRA version: 18.0 Level: LLT Classification code 10001896 Term: Alzheimer's disease System Organ Class: 100000004852 ;Therapeutic area: Diseases [C] - Nervous System Diseases [C10]
- Australia, Austria, Canada, Czech Republic, Denmark, France, Germany, Hungary, Italy, Japan, Korea, Republic of, Portugal, Spain, Taiwan, United Kingdom, United States
- 2015-06-03
Authorised
- 221AD302 Phase 3 Study of Aducanumab in Early Alzheimer's Disease
- Early Alzheimer's Disease MedDRA version: 20.0 Level: LLT Classification code 10001896 Term: Alzheimer's disease System Organ Class: 100000004852 ;Therapeutic area: Diseases [C] - Nervous System Diseases [C10]
- Australia, Austria, Belgium, Canada, Denmark, Finland, France, Germany, Italy, Japan, Korea, Republic of, Netherlands, Poland, Portugal, Spain, Sweden, Taiwan, United Kingdom, United States
- 2015-05-18
Authorised
- A Study of LY3314814 in Participants With Mild Alzheimer's Disease Dementia (Daybreak)
- Alzheimer’s Disease with Dementia MedDRA version: 19.0 Level: PT Classification code 10012271 Term: Dementia Alzheimer's type System Organ Class: 10029205 - Nervous system disorders ;Therapeutic area: Diseases [C] - Nervous System Diseases [C10]
- Canada, China, Czech Republic, Denmark, France, Germany, Italy, Japan, Korea, Republic of, Mexico, Netherlands, Poland, Portugal, Russian Federation, Spain, Taiwan, United Kingdom, United States
- 2016-04-25
Authorised
- A comparison study of TRx0237 (LMTM) and placebo in patients with mild Alzheimer's Disease.
- Alzheimer’s Disease MedDRA version: 20.0 Level: LLT Classification code 10001896 Term: Alzheimer's disease System Organ Class: 100000004852 ;Therapeutic area: Diseases [C] - Nervous System Diseases [C10]
- Belgium, Canada, Hungary, Poland, United Kingdom, United States
- 2017-12-07
Authorised
- A clinical study to investigate the efficacy of Defibrotide Added to Standard of Care Immunoprophylaxis for the prevention of Acute Graft-versus-Host-Disease in adult and pediatric patients after allogeneic hematopoietic stem cell transplant
- Prevention of Acute Graft-versus-Host Disease (aGvHD) after allogeneic hematopoietic stem cell transplant MedDRA version: 20.0 Level: LLT Classification code 10068908 Term: AGVHD System Organ Class: 100000004870 ;Therapeutic area: Body processes [G] - Immune system processes [G12]
- Belgium, Canada, France, Germany, Italy, Spain, Turkey, United Kingdom, United States
- 2017-12-01
Authorised
- A clinical study to investigate the efficacy of Defibrotide Added to Standard of Care Immunoprophylaxis for the prevention of Acute Graft-versus-Host-Disease in adult and pediatric patients after allogeneic hematopoietic stem cell transplant
- Prevention of Acute Graft-versus-Host Disease (aGvHD) after allogeneic hematopoietic stem cell transplant MedDRA version: 20.0 Level: LLT Classification code 10068908 Term: AGVHD System Organ Class: 100000004870 ;Therapeutic area: Body processes [G] - Immune system processes [G12]
- Austria, Belgium, Bulgaria, Canada, Croatia, France, Germany, Greece, Italy, Poland, Portugal, Spain, Turkey, United Kingdom, United States
- 2017-11-28
Authorised
- BI 425809 in patients with cognitive impairment due to Alzheimer's Disease.
- Cognitive impairment due to Alzheimer's Disease Patients with diagnosis of mild-to moderate Alzheimer's dementia according to the recommendations from the National Institute on Aging- Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. MedDRA version: 20.0 Level: PT Classification code 10012271 Term: Dementia Alzheimer's type System Organ Class: 10029205 - Nervous system disorders MedDRA version: 20.0 Level: LLT Classification code 10001896 Term: Alzheimer's disease System Organ Class: 10029205 - Nervous system disorders ;Therapeutic area: Diseases [C] - Nervous System Diseases [C10]
- Austria, Canada, Finland, France, Germany, Greece, Hungary, Italy, Japan, Norway, Spain, United Kingdom, United States
- 2016-04-27
Authorised
- A study evaluating the impact of Itacitinib when added to Ibrutinib for the treatment of relapsed or refractory diffuse large B-Cell lymphoma
- Relapsed or refractory diffuse large B-cell lymphoma MedDRA version: 20.0 Level: PT Classification code 10012822 Term: Diffuse large B-cell lymphoma refractory System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) MedDRA version: 20.0 Level: PT Classification code 10012821 Term: Diffuse large B-cell lymphoma recurrent System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps) ;Therapeutic area: Diseases [C] - Blood and lymphatic diseases [C15]
- Belgium, France, Italy, Netherlands, United Kingdom, United States
- 2018-07-03
Authorised
- A clinical study to investigate the efficacy of Defibrotide Added to Standard of Care Immunoprophylaxis for the prevention of Acute Graft-versus-Host-Disease in adult and pediatric patients after allogeneic hematopoietic stem cell transplant
- Prevention of Acute Graft-versus-Host Disease (aGvHD) after allogeneic hematopoietic stem cell transplant MedDRA version: 20.0 Level: LLT Classification code 10068908 Term: AGVHD System Organ Class: 100000004870 ;Therapeutic area: Body processes [G] - Immune system processes [G12]
- Belgium, Canada, France, Germany, Italy, Spain, Turkey, United Kingdom, United States
- 2017-12-27
Authorised
- A Study to Evaluate the Efficacy, Safety, and Tolerability of Sildenafil Added to Pirfenidone in Patients with Advanced Idiopathic Pulmonary Fibrosis and Intermediate or High Probability of Pulmonary Hypertension due to the lung disease.
- "Pulmonary Hypertension in patients with Idiopathic pulmonary fibrosis (IPF) MedDRA version: 19.0 Level: PT Classification code 10021240 Term: Idiopathic pulmonary fibrosis System Organ Class: 10038738 - Respiratory, thoracic and mediastinal disorders ;Therapeutic area: Diseases [C] - Respiratory Tract Diseases [C08]
- Belgium, Canada, Czech Republic, Egypt, Germany, Greece, Hungary, Israel, Italy, Netherlands, South Africa, Spain, Turkey, United Arab Emirates
- 2016-09-09
